Macquarie Group LTD Myriad Genetics Inc Transaction History

Macquarie Group LTD

$90.3 Billion
Q3 2024

A detailed history of Macquarie Group LTD transactions in Myriad Genetics Inc stock. As of the latest transaction made, Macquarie Group LTD holds 147,593 shares of MYGN stock, worth $2.29 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

147,593

Previous 146,926 0.45%

Holding current value

$2.29 Million

Previous $3.59 Million 12.41%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$23.97 - $28.6 $15,987 - $19,076	667 Added 0.45%	147,593 $4.04 Million
Q2 2024 Aug 09, 2024	SELL	$17.98 - $25.47 $2,013 - $2,852	-112 Reduced 0.08%	146,926 $3.59 Million
Q1 2024 May 14, 2024	SELL	$17.59 - $23.59 $29,762 - $39,914	-1,692 Reduced 1.14%	147,038 $3.13 Million
Q4 2023 Feb 14, 2024	BUY	$13.91 - $21.32 $439,528 - $673,669	31,598 Added 26.98%	148,730 $2.85 Million
Q3 2023 Nov 14, 2023	BUY	$15.99 - $23.22 $20,930 - $30,394	1,309 Added 1.13%	117,132 $1.88 Million
Q2 2023 Aug 14, 2023	SELL	$17.56 - $23.76 $336,748 - $455,645	-19,177 Reduced 14.21%	115,823 $2.68 Million
Q4 2022 Feb 21, 2023	SELL	$14.51 - $20.99 $11,375 - $16,456	-784 Reduced 0.58%	135,000 $1.96 Million
Q3 2022 Nov 14, 2022	SELL	$18.21 - $27.88 $15,223 - $23,307	-836 Reduced 0.61%	135,784 $2.61 Million
Q2 2021 Aug 13, 2021	SELL	$25.39 - $32.61 $35,622 - $45,751	-1,403 Reduced 1.02%	136,620 $4.18 Million
Q1 2021 May 14, 2021	SELL	$19.92 - $31.6 $21,135 - $33,527	-1,061 Reduced 0.76%	138,023 $4.2 Million
Q2 2020 Aug 11, 2020	BUY	$10.69 - $16.49 $8,380 - $12,928	784 Added 0.57%	139,084 $1.58 Million
Q4 2019 Feb 14, 2020	SELL	$20.93 - $35.1 $71,162 - $119,340	-3,400 Reduced 2.4%	138,300 $3.77 Million
Q3 2019 Nov 14, 2019	SELL	$22.08 - $47.08 $117,023 - $249,524	-5,300 Reduced 3.61%	141,700 $4.06 Million
Q2 2019 Aug 14, 2019	BUY	$22.67 - $35.0 $272,040 - $420,000	12,000 Added 8.89%	147,000 $4.08 Million
Q4 2018 Feb 15, 2019	SELL	$27.23 - $45.56 $5,446 - $9,112	-200 Reduced 0.15%	135,000 $3.92 Million
Q3 2018 Nov 15, 2018	SELL	$37.57 - $50.34 $146,523 - $196,326	-3,900 Reduced 2.8%	135,200 $6.22 Million
Q2 2018 Aug 14, 2018	SELL	$27.75 - $40.17 $194,250 - $281,190	-7,000 Reduced 4.79%	139,100 $5.2 Million
Q1 2018 May 11, 2018	BUY	$28.83 - $41.01 $17,298 - $24,606	600 Added 0.41%	146,100 $4.32 Million
Q4 2017 Feb 15, 2018	BUY	$28.45 - $37.14 $298,725 - $389,970	10,500 Added 7.78%	145,500 $5 Million
Q3 2017 Nov 08, 2017	BUY	$24.01 - $36.2 $3.24 Million - $4.89 Million	135,000	135,000 $4.88 Million

Others Institutions Holding MYGN

# of Institutions

253

Shares Held

90.9M

Call Options Held

100K

Put Options Held

34K

View Full List

About MYRIAD GENETICS INC

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.25B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

More about MYGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Account

Macquarie Group LTD Myriad Genetics Inc Transaction History